These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33619472)

  • 21. Expansion of CD10
    Fraccarollo D; Neuser J; Möller J; Riehle C; Galuppo P; Bauersachs J
    Elife; 2021 Jul; 10():. PubMed ID: 34289931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired IFN-γ-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients.
    Cordes F; Lenker E; Weinhage T; Spille LJ; Bettenworth D; Varga G; Schmidt HH; Foell D
    Inflamm Bowel Dis; 2021 May; 27(6):887-901. PubMed ID: 33165509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells.
    Okada S; Han S; Patel ES; Yang LJ; Chang LJ
    Immunol Cell Biol; 2015; 93(5):461-71. PubMed ID: 25582338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes.
    Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
    bioRxiv; 2020 Nov; ():. PubMed ID: 33140051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship Between T-Cell Exosomes and Cellular Subsets in SLE According to Type I IFN-Signaling.
    López P; Rodríguez-Carrio J; Caminal-Montero L; Suárez A
    Front Med (Lausanne); 2020; 7():604098. PubMed ID: 33330567
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
    Xiang S; Dong NG; Liu JP; Wang Y; Shi JW; Wei ZJ; Hu XJ; Gong L
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating immune cell landscape and T-cell abnormalities in patients with moyamoya disease.
    Ge P; Tao C; Wang W; He Q; Liu C; Zheng Z; Mou S; Zhang B; Liu X; Zhang Q; Wang R; Li H; Zhang D; Zhao J
    Clin Transl Med; 2024 Apr; 14(4):e1647. PubMed ID: 38566524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baricitinib restrains the immune dysregulation in patients with severe COVID-19.
    Bronte V; Ugel S; Tinazzi E; Vella A; De Sanctis F; Canè S; Batani V; Trovato R; Fiore A; Petrova V; Hofer F; Barouni RM; Musiu C; Caligola S; Pinton L; Torroni L; Polati E; Donadello K; Friso S; Pizzolo F; Iezzi M; Facciotti F; Pelicci PG; Righetti D; Bazzoni P; Rampudda M; Comel A; Mosaner W; Lunardi C; Olivieri O
    J Clin Invest; 2020 Dec; 130(12):6409-6416. PubMed ID: 32809969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.
    Hammoudeh SM; Hammoudeh AM; Bhamidimarri PM; Al Safar H; Mahboub B; Künstner A; Busch H; Halwani R; Hamid Q; Rahmani M; Hamoudi R
    Front Immunol; 2021; 12():595150. PubMed ID: 34262555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling.
    Hackney JA; Shivram H; Vander Heiden J; Overall C; Orozco L; Gao X; Kim E; West N; Qamra A; Chang D; Chakrabarti A; Choy DF; Combes AJ; Courau T; Fragiadakis GK; Rao AA; Ray A; Tsui J; Hu K; Kuhn NF; Krummel MF; Erle DJ; Kangelaris K; Sarma A; Lyon Z; Calfee CS; Woodruff PG; Ghale R; Mick E; Byrne A; Zha BS; Langelier C; Hendrickson CM; van der Wijst MGP; Hartoularos GC; Grant T; Bueno R; Lee DS; Greenland JR; Sun Y; Perez R; Ogorodnikov A; Ward A; Ye CJ; ; Ramalingam T; McBride JM; Cai F; Teterina A; Bao M; Tsai L; Rosas IO; Regev A; Kapadia SB; Bauer RN; Rosenberger CM
    iScience; 2023 Oct; 26(10):107813. PubMed ID: 37810211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4
    de Franca MNF; Rodrigues LS; Barreto AS; da Cruz GS; Aragão-Santos JC; da Silva AM; de Jesus AR; Palatnik-de-Sousa CB; de Almeida RP; Corrêa CB
    Front Immunol; 2024; 15():1277557. PubMed ID: 38410517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stress-induced redistribution of immune cells--from barracks to boulevards to battlefields: a tale of three hormones--Curt Richter Award winner.
    Dhabhar FS; Malarkey WB; Neri E; McEwen BS
    Psychoneuroendocrinology; 2012 Sep; 37(9):1345-68. PubMed ID: 22727761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
    Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Worsening of imiquimod-induced psoriasiform inflammation in mice by environmental pollutant, di-(2-ethylhexyl) phthalate through dysregulation in IL-17A and Nrf2/iNOS signaling in peripheral myeloid and CD4 + T cells.
    Alfardan AS; Nadeem A; Ahmad SF; Al-Harbi NO; Alqinyah M; Attia SM; Sarawi W; Alanazi AZ; Alhazzani K; Ibrahim KE
    Int Immunopharmacol; 2024 Jan; 126():111293. PubMed ID: 38056199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Inverse Relationship Between c-Kit/CD117 and mTOR Confers NK Cell Dysregulation Late After Severe Injury.
    Bösken B; Hepner-Schefczyk M; Vonderhagen S; Dudda M; Flohé SB
    Front Immunol; 2020; 11():1200. PubMed ID: 32670280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell type-specific immune dysregulation in severely ill COVID-19 patients.
    Yao C; Bora SA; Parimon T; Zaman T; Friedman OA; Palatinus JA; Surapaneni NS; Matusov YP; Chiang GC; Kassar AG; Patel N; Green CE; Aziz AW; Suri H; Suda J; Lopez AA; Martins GA; Stripp BR; Gharib SA; Goodridge HS; Chen P
    medRxiv; 2020 Jul; ():. PubMed ID: 32743611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effector T Cell Resistance to Suppression and STAT3 Signaling during the Development of Human Type 1 Diabetes.
    Ihantola EL; Viisanen T; Gazali AM; Näntö-Salonen K; Juutilainen A; Moilanen L; Rintamäki R; Pihlajamäki J; Veijola R; Toppari J; Knip M; Ilonen J; Kinnunen T
    J Immunol; 2018 Aug; 201(4):1144-1153. PubMed ID: 30006377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory impact of IFN-γ in CD8+ T cell-mediated lung injury is mediated by both Stat1-dependent and -independent pathways.
    Ramana CV; DeBerge MP; Kumar A; Alia CS; Durbin JE; Enelow RI
    Am J Physiol Lung Cell Mol Physiol; 2015 Apr; 308(7):L650-7. PubMed ID: 25617378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leptin correlates with monocytes activation and severe condition in COVID-19 patients.
    Wang J; Xu Y; Zhang X; Wang S; Peng Z; Guo J; Jiang H; Liu J; Xie Y; Wang J; Li X; Liao J; Wan C; Yu L; Hu J; Liu B; Liu Z
    J Leukoc Biol; 2021 Jul; 110(1):9-20. PubMed ID: 33404078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome Is Associated With Dysregulation of IL-7/IL-7 Receptor Signaling Pathway in T Cells and Monocyte Activation.
    Akilimali NA; Muema DM; Specht C; Chang CC; Moosa MS; Levitz SM; Lewin SR; French MA; Ndungʼu T
    J Acquir Immune Defic Syndr; 2019 Apr; 80(5):596-604. PubMed ID: 30649031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.